Summary
The the urinary excretion patterns of theophylline metabolites were studied in a subject on a routine, oral dose of 600 mg/day. The highest correlation was observed between the excretions of 1,3-dimethylurate and 1-methylurate (r=0.73±0.08). The poorest correlations were observed when the excretion of 1-methylxanthine was compared to those of 1-methylurate and 1,3-dimethylurate (r ≤0.55,P≥0.05). The difference in the quality of the correlations was not due to rate-limiting or class-specific carriers. The results suggested that 1-methylurate did not derive solely from 1-methylxanthine, implicating 1,3-dimethylurate as an alternative source. When the theophylline regimen was supplemented by a single dose of caffeine (4.80 mg/kg), the recovery of unaltered caffeine and the yield of metabolites arising from the primary 3-demethylation of caffeine (1-methylxanthine, 7-methylxanthine, 1-methylurate, 1,7-dimethylxanthine and 1,7-dimethylurate) were found to be unchanged. The lack of competition between caffeine and theophylline indicated that caffeine 3-demethylation and the demethylations of theophylline are not catalyzed by the same cytochrome P450 system.
Similar content being viewed by others
References
Grygiel J.J., Wing L.M.H., Farkas J., Birkett D.J. (1979): Effects of allopurinol on theophylline metabolism and clearance. Clin. Pharmacol. ther., 26, 660–667.
Jonkman J.H.G., Sollie F.A.E., Sauter R., Steinijans V.W. (1991): The influence of caffeine on steady-state pharmacokinetics of theophylline. Clin. Pharmacol. Ther., 49, 248–255.
Gu L. Gonzalez F.J., Kalow W., Tang B.K. (1992): Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics, 2, 73–77.
Birkett D.J., Miners J.O., Day R.O. (1991): I-Methylxanthine derived from theophylline as an in vivo biochemical probe of allopurinol effect. Br. J. Clin. Pharmacol., 32, 238–241.
Antal E.J., Kramer P.A., Mercik S.A., Chapron D.J., Lawson J.R. (1981): Theophylline pharmacokinetics in advanced age. Br. J. Clin. Pharmacol., 12, 637–645.
Birkett D.J., Miners J.O., Atwood J. (1983): Secondary metabolism of theophylline biotransformation products in man — route of formation of 1-methyluric acid. Br. J. Clin. Pharmacol., 15, 117–119.
Robson R.A., Matthews A.P., Miners J.O. et al. (1987): Characterization of theophylline metabolism in human liver microsomes. Br. J. Clin. Pharmacol., 24, 293–300.
Sarkar M.A., Hunt C., Guzelian P.S., Karnes H.T. (1992): Characterization of human liver cytochrome P-450 involved in theophylline metabolism. Drug. Metab. Dispos., 20, 31–37.
Grant D.M., Tang B.K., Kalow W. (1983): Variability in caffeine metabolism. Clin. Pharmacol. Ther., 33, 591–602.
Tang-Liu D.D.S., Williams R.L., Riegelman S. (1983): Disposition of caffeine and its metabolites in man. J. Pharmacol. Exp. Ther., 224, 180–185.
McClure W.R. (1969): A kinetic analysis of coupled enzyme assays. Biochemistry, 8, 2782–2786.
Lelo A., Kjellen G., Birkett D.J., Miners J.O. (1989): Paraxanthine metabolism in humans: determination of metabolic partial clearances and effects of allopurinol and cimetidine. J. Pharmacol. Exp. Ther., 248, 315–319.
Fuhr U., Doehmer J., Battula N. et al. (1993): Biotransformation of methylxanthines in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms. Allocation of metabolic pathways to isoforms and inhibitory effects of quinolones. Toxicology, 82, 169–189.
Butler M.A., Iwasaki M, Guengerich F.P., Kadlubar F.F. (1989): Human cytochrome P450 pa (P-4501A2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Biochemistry, 86, 7696–7670.
Berthou F., Finois J.P., Ratanasavanh D., Beaune P., Riche C., Guillozou A. (1991): Evidence for the involvement of several cytochromes P450 in the first steps of caffeine metabolism by human liver microsomes. Drug Metab. Dispos., 19, 561–567.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bayar, C., Özer, I. A study on the route of 1-methylurate formation in theophylline metabolism. Eur. J. Drug Metab. Pharmacokinet. 22, 415–419 (1997). https://doi.org/10.1007/BF03190979
Issue date:
DOI: https://doi.org/10.1007/BF03190979

